E009 Caracterisation des microparticules circulantes chez les patients atteints du syndrome des anticorps anti-phospholipides  by Merhi-Soussi, F. et al.
S50 Abstracts
treated with healthy subjects MPs did not affect  ow-induced 
dilation, these vessels showed a reduced prostacyclin-component 
that was completely compensated by the NO-component of the 
response. The endothelial dysfunction induced by MPs from OSAS 
was caused by the reduction of both NO- and prostacyclin- but 
not the endothelium-derived hyperpolarizing factor-components of 
the response in SMA. These data provide evidence that circulating 
MPs from OSAS patients in uence both endothelial function and 
vascular reactivity.
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During cell activation or apoptosis, cells release vesicles, also 
called microparticles (MPs) from the plasma membrane. Since 
composition of MPs is dependent on cell origin and the type of 
stimulation, we compared the effects of MPs generated from both 
apoptotic T lymphocytes and apoptotic monocytes on endothelial 
function with respect to both nitric oxide (NO) pathway and 
reactive oxygen species (ROS). MPs were produced by treatment of 
either human T lymphocytes with the apoptotic agent actinomycin 
D or human monocytic cell line THP-1 with the apoptotic agent, 
the etoposide VP-16. Human Eahy 926 endothelial cells were 
incubated with 10 g/ml MPs for 24h. Apoptotic MPs from human 
T lymphocytes decreased NO production that was associated 
with overexpression and phosphorylation of endothelial NO-
synthase (eNOS). Also, T lymphocytes MPs enhanced expression 
of caveolin-1 and decreased its phosphorylation. T lymphocytes 
MPs enhanced ROS by a mechanism sensitive to xanthine oxidase 
and P-IkappaBalpha inhibitors. PI3-kinase inhibition reduced the 
effects of T lymphocytes MPs on eNOS, but not on caveolin-1, 
whereas it enhanced the effects of MPs on ROS production. 
Inhibition of MEK reversed eNOS phosphorylation but it had 
no effect on ROS production induced by T lymphocytes MPs. 
By contrast, apoptotic MPs from human monocytes increased 
both NO production and in much less extent ROS. These effects 
were associated with a decrease of caveolin-1 expression and 
increased its phosphorylation, without affecting eNOS expression 
and phosphorylation. The inhibitor of the PI-3kinase, LY294002, 
reversed the effects of monocyte MPs on caveolin-1 expression 
but not on its phosphorylation. The MEK1/2 inhibitor, U0126, 
reversed the decrease of caveolin-1 expression induced by MPs 
from monocytes. Interestingly, U0126 potentiated ROS production 
induced by monocyte MPs. Whereas in vivo injection of T 
lymphocytes MPs in mice impaired endothelial function, apoptotic 
MPs from human monocytes did not affect endothelium-dependent 
relaxation. In addition, monocyte MPs were able to promote in 
vitro angiogenesis. In summary, these results highlight differential 
effects of apoptotic MPs from different origins by activating 
diverse multiple pathways related to NO and ROS productions.
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Telomerase, a ribonucleoprotein enzyme, catalyses the synthesis 
of repeated telomeric sequences. Telomeres are required for 
chromosome stability and cell viability and a decrease of their 
length was found to be associated with several cardiovascular 
diseases. Telomerase contains the hTR RNA, and several proteins, 
including the reverse transcriptase hTERT. The hTR 5’ domain 
contains the template sequence for DNA synthesis and binds hTERT. 
The H/ACA 3’ domain is required for stability and associates with 
4 proteins (Dyskerin, GAR1, NOP10 and NHP2 proteins). Limited 
information is available on telomerase assembly. A pre-complex 
containing Dyskerine, NOP10, NHP2 and an assembly factor, called 
NAF1, is likely formed in the cytoplasm and transported to the 
nucleus, where it associates with the H/ACA domain of nascent 
RNA. Exchange of NAF1 for GAR1 allows the production of the 
functional H/ACA RNP domain. We showed that several factors 
are implicated in H/ACA RNP assembly : NUFIP, the R2TP complex, 
and HSP90. The SMN complex, containing the SMN, Gemin2 to 
Gemin8 and Unrip proteins may also be involved, since protein SMN 
interacts with GAR1.
For further analysis on the role of the SMN complex in telomerase 
assembly, we tested by yeast two hybrid assays whether other 
proteins of this complex can interact with H/ACA RNP proteins 
and their assembly factors. We discovered a possible interaction 
between NAF1, Gemin 3 and Gemin8. Hence, the SMN complex may 
be involved in the replacement of NAF1 by GAR1 : it may associate 
with GAR1 through an interaction with SMN, and with the pre-H/
ACA RNP complex through interaction of NAF1 with Gemin3 and 
8, allowing the replacement of NAF1 by GAR1. We are testing this 
hypothesis. The SMN complex may also be involved in hTERT binding 
to the 5’ domain of hTR and we will also explore this possibility.
Through these studies we should bring insight into telomerase 
assembly that may be useful to understand telomere attrition in 
cardiovascular diseases.
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Contexte — Les MP sont générées par le remaniement de la 
membrane plasmique suite à l’activation des cellules sanguines ou 
des cellules endothéliales.
Objectif — Nous avons caractérisé les microparticules circulantes 
chez les patients atteints du syndrome des anticorps anti-
phospholipides (SAPL), thrombophilie acquise caractérisée par un 
risque augmenté de thromboses et de complications obstétricales. 
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Les anticorps anti-phospholipides (APL) jouent un rôle majeur dans 
ces manifestations, impliquant probablement une altération de 
la fonction endothéliale ce qui induit un état prothrombotique, 
venant ampli er les effets procoagulants sur les plaquettes.
Méthodes — Nous avons quanti é les MP dans le plasma et déterminé 
leur origine cellulaire par la cytométrie en  ux. Le plasma dépourvu 
en plaquette (PDP) a été préparé, selon les recommandations de 
la société internationale de thrombose et d’hémostase. Grâce 
à des billes calibrées en taille, nous avons délimité une fenêtre 
d’analyse des évènements de taille de 0.5 à 1,5 m, marquées 
par les anticorps spéci ques anti-CD41 et anti-CD31 (double 
marquage) pour identi er les MP plaquettaires, anti-CD45 pour les 
MP leucocytaires, anti-CD235a pour les MP érythrocytaires et anti-
CD144 pour les MP endothéliales. L’utilisation de billes  uorescentes 
en quantité connue nous a permis de les quanti er.
Résultats — 23 patients SAPL ont été inclus selon les critères de 
classi cation actualisés à la conférence internationale de Sydney, 
publiés en 2006, à savoir l’association d’au moins un évènement 
clinique (thromboses artérielles et/ou veineuses, manifestations 
obstétricales) et présence d’APL. Nous avons observé chez le 
groupe de patients SAPL en comparaison au groupe de sujets 
témoins (24 sujets) une augmentation signi cative du nombre 
de MP plaquettaire (1.7 fois, p < 0.029), endothéliale (1.7 fois, p 
< 0.04), leucocytaire (1.6 fois, p < 0.03) et érythrocytaire (1,4 fois, 
p < 0.016).
Conclusions — Nos résultats montrent des niveaux élevés de 
microparticules circulantes chez les patients atteints de SAPL 
suggérant une augmentation de l’activation cellulaire probablement 
associée aux évènements cliniques. Nous incluons actuellement un 
deuxième groupe de patients présentant des signes biologiques (la 
présence d’APL) sans thromboses ni manifestations obstétricales 
pour comparer le niveau et/ou l’origine des MP chez les patients 
symptomatiques et asymptomatiques.
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Among the proposed hypothesis for in ammatory bowel disease 
(IBD) pathogenesis, a vascular cause has been suggested, mostly 
in reference to anatomic and pathological studies. We previously 
reported in small mesenteric arteries from Crohn’s disease patients 
a balance between vasoconstrictor products from cyclooxygenase 
and unidenti ed vasodilatory products that maintained vascular 
reactivity in a physiological range despite an increase of circulatory 
cytokines in these patients (Tabernero et al., Circulation, 2003). 
Microparticles (MPs) are membrane vesicles released during cell 
activation and apoptosis. Elevated levels of circulating MPs have 
been detected in pathologic conditions and their increase has been 
associated with disease activity and/or prognosis. We investigated 
whether MPs from IBD patients may play a role in the regulation of 
endothelial function and vascular reactivity in this disease. Blood 
samples were obtained either from IBD patients as well as age and 
sex-matched healthy subjects. MPs concentration and origin were 
assessed by  ow cytometry using speci c antibodies. Male Swiss 
mice were injected intravenously with MPs from IBD patients or with 
saline solution and sacri ed after 24 hours. Endothelial function and 
vascular reactivity were studied on aortic rings and small mesenteric 
resistance arteries (SMA) by myography and arteriography, 
respectively. Patients with IBD displayed increased circulating levels 
of MPs compared to healthy subjects including those from pro-
coagulant, platelet and activated platelet, endothelial, leukocyte 
and erythrocyte origins. In aorta, MPs from IBD patients compared 
to saline signi cantly reduced both endothelium-dependent 
relaxation to acetylcholine and contraction to serotonin. In SMA, 
although MPs from IBD patients did not affect  ow-induced dilation, 
a reduced NO-component that was completely compensated by 
the endothelium-derived hyperpolarizing factor-component of the 
response was highlighted. Besides, MPs from IBD did not affect 
myogenic tone in SMA. These results provide further evidence of 
increased circulating levels of MPs in patients with IBD. MPs origin 
may play a role in enhanced coagulation and in ammatory states 
reported in IBD patients. Finally, MPs from IBD patients in uence 
both endothelial dysfunction and vascular hyporeactivity in the 
experimental model used.
(Partially supported by Ferring France Laboratories).
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Dietary supplements in polyunsaturated fatty acids (PUFA), 
particularly omega-3, are well known for the bene cial role that 
they play in preventing cardiovascular diseases. The aim of this 
study was to determine the role of PUFA on the modulation of 
apoptosis induced by hypochlorous acid oxidized LDL (HOCl-oxLDL) 
in U937 monocytic cell lines, and the impact on atherosclerosis in 
Apolipropotein E-knockout (ApoE-/-) mice.
We tested the potential effect on modulation of HOCl-oxLDL-
induced apoptosis after a cellular membrane overloading with 
eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), 
arachidonic acid (ARA) or oleic acid (OA). We showed that 
both EPA and ARA, exerted a pro-apoptotic effect through a 
speci c activation of the intrinsic mitochondrial apoptotic 
pathway including an increase in DNA fragmentation, a speci c 
activation of caspase activity and protein expression and a loss 
of mitochondrial membrane potential. In parallel, three groups 
of ApoE-/- mice were fed on diet supplemented with EPA, or 
DHA, or not, for 5- or 12-weeks. Whatever the treatment, serum 
cholesterol concentrations were similar in the three groups and 
PUFA supplementation do not appeared to prevent development 
of atherosclerotic plaques measured by oil red O-staining of 
descending aorta or aortic sinus.
These data demonstrate a novel function of dietary supplements in 
PUFA with likely consequences in apoptosis in cultured monocytes, 
with no protection against atherosclerosis development in ApoE-
/- mice.
